Procaps Group, S.A Current Ratio 2020-2023 | PROCF
Procaps Group, S.A current ratio from 2020 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Procaps Group, S.A Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-09-30 |
$0.30B |
$0.20B |
1.47 |
| 2023-06-30 |
$0.30B |
$0.24B |
1.21 |
| 2023-03-31 |
$0.27B |
$0.23B |
1.15 |
| 2022-12-31 |
$0.30B |
$0.37B |
0.81 |
| 2022-09-30 |
$0.30B |
$0.22B |
1.38 |
| 2022-06-30 |
$0.30B |
$0.19B |
1.54 |
| 2022-03-31 |
$0.31B |
$0.22B |
1.40 |
| 2021-12-31 |
$0.30B |
$0.19B |
1.59 |
| 2021-09-30 |
$0.31B |
$0.28B |
1.13 |
| 2021-06-30 |
$0.00B |
$0.00B |
0.05 |
| 2021-03-31 |
$0.00B |
$0.00B |
5.43 |
| 2020-12-31 |
$0.19B |
$0.24B |
0.77 |
| 2020-09-30 |
$0.00B |
$0.00B |
7.28 |
| 2020-06-30 |
$0.00B |
$0.00B |
11.18 |
| 2020-03-31 |
$0.00B |
$0.00B |
20.15 |
| 2019-12-31 |
$0.00B |
$0.00B |
25.58 |
| 2019-09-30 |
$0.00B |
$0.00B |
0.12 |
| 2019-06-30 |
$0.00B |
|
0.00 |
| 2019-03-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
